S&Co Inc Abbott Laboratories Transaction History

S&Co Inc

$1.43 Billion
Q2 2024

A detailed history of S&Co Inc transactions in Abbott Laboratories stock. As of the latest transaction made, S&Co Inc holds 259,511 shares of ABT stock, worth $29.6 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares

259,511

Previous 266,739 2.71%

Holding current value

$29.6 Million

Previous $30.3 Million 11.06%

% of portfolio

1.88%

Previous 2.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $728,076 - $812,716	-7,228 Reduced 2.71%	259,511 $27 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $18,759 - $22,963	208 Added 0.08%	266,739 $29.4 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $21,971 - $26,362	230 Added 0.09%	266,531 $25.8 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $88,484 - $98,590	-878 Reduced 0.33%	266,301 $29 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $950 - $1,115	-10 Reduced -0.0%	267,179 $29.3 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $22,835 - $26,439	-236 Reduced 0.09%	267,189 $25.9 Million
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $453,190 - $547,762	-4,440 Reduced 1.63%	267,425 $29.1 Million
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $78,673 - $95,937	-690 Reduced 0.25%	271,865 $32.2 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $119,111 - $145,845	-1,031 Reduced 0.38%	272,555 $38.4 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $9,332 - $10,324	-80 Reduced 0.03%	273,586 $32.3 Million
Q2 2021 Jul 14, 2021	SELL	$105.79 - $124.53 $416,283 - $490,025	-3,935 Reduced 1.42%	273,666 $31.7 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $19,591 - $23,081	-180 Reduced 0.06%	277,601 $33.3 Million
Q4 2020 Jan 28, 2021	SELL	$105.0 - $114.42 $172,725 - $188,220	-1,645 Reduced 0.59%	277,781 $30.4 Million
Q3 2020 Dec 11, 2020	SELL	$91.64 - $111.29 $60,940 - $74,007	-665 Reduced 0.24%	279,426 $30.4 Million
Q2 2020 Dec 16, 2020	SELL	$76.57 - $98.0 $6,508 - $8,330	-85 Reduced 0.03%	280,091 $25.6 Million
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $65,018 - $95,075	-1,035 Reduced 0.37%	280,176 $22.1 Million
Q4 2019 Jan 24, 2020	BUY	$78.51 - $87.4 $70,344 - $78,310	896 Added 0.32%	281,211 $24.4 Million
Q3 2019 Oct 29, 2019	BUY	$81.84 - $88.74 $139,537 - $151,301	1,705 Added 0.61%	280,315 $23.5 Million
Q2 2019 Jul 23, 2019	SELL	$72.88 - $85.0 $79,803 - $93,075	-1,095 Reduced 0.39%	278,610 $23.4 Million
Q1 2019 Apr 24, 2019	BUY	$66.22 - $80.06 $31,785 - $38,428	480 Added 0.17%	279,705 $22.4 Million
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $25,896 - $29,336	-395 Reduced 0.14%	279,225 $20.2 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $46,215 - $55,753	-760 Reduced 0.27%	279,620 $20.5 Million
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $13.5 Million - $15 Million	280,380	280,380 $15 Million

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

News

Stay updated on S&Co Inc with notifications on news.

Account